Retatrutide is a newly developed therapy that acts as a powerful GLP-1 receptor activator. This revolutionary approach holds significant potential for regulating type 2 diabetes. By replicating the actions of natural GLP-1, Retatrutide enhances insulin secretion and limits glucagon release, leading to improved glycemic control. Clinical trials h… Read More